3158 results for «362»
3158 results
Complications and bailout strategies in transcatheter mitral interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses complications encountered during transcatheter mitral valve edge-to-edge repair (TEER), focusing on their identification, management, and prevention. Through case studies and interactive discussions, participants gain insights into optimizing case selection and implementing effective bailout strategies to ensure procedural safety.
Closing Ceremony
15 Feb 2026 – From PCR Tokyo Valves 2026
The Closing Ceremony marked the culmination of the conference, providing a formal conclusion to the event and reflecting on the key advancements and discussions in interventional cardiology presented throughout the sessions.
Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER
13 Feb 2026 – From PCR Tokyo Valves 2026
Delve into mitral regurgitation assessment and the suitability criteria for Transcatheter Edge-to-Edge Repair (TEER). This session reviews mitral valve anatomy, advanced echocardiographic and CT imaging techniques, and the latest clinical data guiding TEER application.
The next generation DES technology: innovative DES+DCB stent platform
Next generation of DES technology, what it's all about? Find out in this session where experts will present complex cases from around the world and discuss the new indications for which they can be used.
TAVI: LIVE Educational Case from Nagoya Heart Center - Nagoya, Japan
15 Feb 2026 – From PCR Tokyo Valves 2026
This live educational case from Nagoya Heart Center provides detailed insights into TAVI procedural optimization, focusing on index valve selection for lifetime management and strategies to address highly calcified, small aortic annuli. Attendees benefit from stepwise procedural demonstrations, operator strategies, imaging analysis, and discussions on facilitating...
Future devices and techniques for structural heart disease
15 Feb 2026 – From PCR Tokyo Valves 2026
Explore the future landscape of structural heart disease treatment by examining current limitations of transcatheter valvular technologies. This session discusses emerging devices and innovative techniques for aortic, mitral, and tricuspid valve interventions, providing a forward-looking perspective on therapeutic advancements.
Guidelines update
15 Feb 2026 – From PCR Tokyo Valves 2026
Review the latest updates to the ESC/EACTS guidelines with a focus on their impact for managing structural heart disease. Key topics include new age cutoffs and asymptomatic disease management in aortic valve interventions, revised mitral valve recommendations, integration of tricuspid TEER and TTVR, and clinical implications...
Newly emerging devices from Asia and upcoming trials on new TAVI frontier
14 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights newly emerging transcatheter aortic valve implantation (TAVI) devices from Asia and presents ongoing and upcoming clinical trials exploring innovative TAVI frontiers. It provides insights into the evolving device landscape and evidence shaping future directions in TAVI therapy.
Team approach to structural heart disease: how to handle unexpected situations
14 Feb 2026 – From PCR Tokyo Valves 2026
This session emphasizes the importance of a multidisciplinary team approach in managing unexpected events during structural heart disease interventions. Through real-world examples, it highlights the roles and responses of radiologic technologists, clinical engineers, sonographers, and nursing staff in effectively addressing intraoperative complications and postoperative challenges to...
Procedural optimisation for enhanced acute and long-term outcomes
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delves into procedural optimization techniques for transcatheter aortic valve implantation (TAVI) to enhance both acute and long-term outcomes. It discusses critical procedural factors such as valve sizing, expansion, implantation depth, and commissural alignment, and their role in valve durability and survival. Practical cathlab cases...
Patient selection for tricuspid TEER in 2026
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delineates criteria for optimal patient selection for tricuspid transcatheter edge-to-edge repair (TEER) in 2026. Integrating anatomical, haemodynamic, and clinical parameters, it clarifies the evolving indications relative to transcatheter tricuspid valve replacement (TTVR) and conservative management. Real-world cases informed by pivotal trials such as TRILUMINATE,...
Getting ready for tricuspid TEER: key steps in building a successful programme
14 Feb 2026 – From PCR Tokyo Valves 2026
Prepare to build a successful tricuspid TEER program with systematic approaches to patient selection, echocardiographic assessment, and procedural fundamentals. This session includes case demonstrations and reviews recent clinical evidence to support program development.
Transcatheter valve-in-valve intervention: LIVE Educational Case from The Prince Charles Hospital, Metro North Health - Brisbane, Australia
14 Feb 2026 – From PCR Tokyo Valves 2026
Experience a live educational case on transcatheter valve-in-valve intervention highlighting anatomical challenges, the critical role of pre-procedural CT imaging, and meticulous planning to prevent life-threatening complications and achieve favorable long-term outcomes.
Mastering techniques from basic to complex - Tips and tricks for advanced mitral TEER: anatomy and imaging
13 Feb 2026 – From PCR Tokyo Valves 2026
This session offers advanced insights into mitral TEER, emphasizing anatomical understanding and imaging to improve clinical outcomes. It also addresses device function, procedural steps, and management of common complications to refine interventional skills.
Mastering techniques from basic to complex - Tricuspid TEER fundamentals
13 Feb 2026 – From PCR Tokyo Valves 2026
Gain foundational knowledge in tricuspid TEER, covering anatomical criteria for patient suitability, key procedural steps, and advanced device techniques. The session includes practical insights using a beating heart simulator to enhance procedural expertise.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
Comparison of drug-coated versus conventional balloons for treatment of side branches of bifurcation lesions: the OCVC-BIF study
29 Oct 2025
Ali Nazmi Calik provides his take on the OCVC-BIF study presented by Takayuki Ishihara at TCT 2025, in San Francisco.
Author
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.
Author
Author
Author
